CORD-19:0329e0f2e3b8ab0eabe2afe0e5214cc88c61080e / 20271-20441 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T113","span":{"begin":0,"end":170},"obj":"Sentence"},{"id":"T4018","span":{"begin":0,"end":170},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Notably, as a broad spectrum anti-RNA virus drug, favipiravir has been submitted for additional indications for SFTS in Japan, based on clinical trials (Yasukawa, 2016) ."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T113","span":{"begin":0,"end":170},"obj":"Sentence"}],"text":"Notably, as a broad spectrum anti-RNA virus drug, favipiravir has been submitted for additional indications for SFTS in Japan, based on clinical trials (Yasukawa, 2016) ."}

    Epistemic_Statements

    {"project":"Epistemic_Statements","denotations":[{"id":"T29","span":{"begin":0,"end":170},"obj":"Epistemic_statement"}],"text":"Notably, as a broad spectrum anti-RNA virus drug, favipiravir has been submitted for additional indications for SFTS in Japan, based on clinical trials (Yasukawa, 2016) ."}